Kidswell Bio Corporation, The Current Fiscal Year's Net Income to Narrow

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Tue Nov 12, 2024 4:00 pm JST Earnings

4584 Kidswell Bio Corporation 【J-GAAP】

Earnings Report

Kidswell Bio Corporation <4584> [TSE-G] announced its financial results after the market closed on November 12th (16:00). The consolidated net loss for the cumulative second quarter of the fiscal year ending March 2025 (April to September) was a reduced loss of 241 million yen (compared to a loss of 780 million yen in the previous period non-consolidated).

In addition, the consolidated net loss for the full year further decrease to loss of 950 million yen (compared to a loss of 1.42 billion yen in the previous period non-consolidated).

Based on the first-half performance announced by the company and the full-year plan, our calculation indicates that the consolidated net loss for the October to March period (second half) is expected to expand to a loss of 709 million yen (compared to a loss of 642 million yen in the previous period non-consolidated).

In the most recent three-month period, from July to September (2Q), the consolidated net loss improved to a deficit of loss of 65 million yen (compared to a loss of 310 million yen in the previous period non-consolidated). The operating profit/loss margin drastically improved from -49.3% in the same period last year to -8.2%.

Note: Since the current fiscal year, the company has transitioned to consolidated financial statements.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2022	1,116	11	-42	-42	-1.4	ー	Nov 8, 2022	J-GAAP
Apr - Sep, 2023	581	-719	-744	-780	-24.1	ー	Nov 8, 2023	J-GAAP
Apr - Sep, 2024	1,749	-262	-267	-241	-6.1	ー	Nov 12, 2024	J-GAAP
YoY	+201.0%	+63.6%	+64.1%	+69.1%	+74.7%

First Half Results vs. Previous Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Apr - Sep, 2024 Guidance	ー	ー	ー	ー	－	0	May 14, 2024	J-GAAP
Apr - Sep, 2024 Results	1,749	-262	-267	-241	-6.1	0	Nov 12, 2024	J-GAAP
Revision Rate	－	－	－	－	－

Guidance Update

Full Year Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2025 Prev	4,000	ー	ー	ー	－	0	May 14, 2024	J-GAAP
Mar, 2025 New	4,000	-1,000	-1,000	-950	-23.4	0	Nov 12, 2024	J-GAAP
Revision Rate	0.0%	－	－	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	1,850	-616	-645	-642	-18.2	0	May 14, 2024	J-GAAP
Oct - Mar, 2024 Guidance	2,251	-738	-733	-709	-17.4	0	Nov 12, 2024	J-GAAP
YoY	+21.7%	-19.8%	-13.6%	-10.4%	+4.0%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	2,776	-550	-624	-657	-20.8	0	May 12, 2023	J-GAAP
Mar, 2024	2,431	-1,335	-1,389	-1,422	-40.2	0	May 14, 2024	J-GAAP
Mar, 2025 Guidance	4,000	-1,000	-1,000	-950	-23.4	0	Nov 12, 2024	J-GAAP
YoY	+64.5%	+25.1%	+28.0%	+33.2%	+41.9%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jul - Sep, 2023	536	-264	-274	-310	-9.6	-49.3	Nov 8, 2023	J-GAAP
Oct - Dec, 2023	985	52	32	33	1.0	5.3	Feb 7, 2024	J-GAAP
Jan - Mar, 2024	865	-668	-677	-675	-19.1	-77.2	May 14, 2024	J-GAAP
Apr - Jun, 2024	482	-158	-176	-176	-4.5	-32.8	Aug 14, 2024	J-GAAP
Jul - Sep, 2024	1,267	-104	-91	-65	-1.6	-8.2	Nov 12, 2024	J-GAAP
YoY	+136.4%	+60.6%	+66.8%	+79.0%	+82.9%